Rosenstock stated in the Regeneron press release: These complete 26-week COURAGE results demonstrate a meaningful opportunity to preserve muscle mass while enhancing fat loss. Also noted: Numerical improvements in metabolic and lipid parameters, secondary and exploratory endpoints, were seen across all treatment groups, including improvements in waist circumference, blood pressure, cholesterol, triglycerides and A1C. Read the full press release:
Hashimoto H, Satoh M, Nakayama S, Toyama M, Murakami T, Obara T, Nakaya N, Mori T, Hozawa A, Metoki H
That is the main reason a shot tends to act faster than a tablet
People who experience severe side effects or other issues when they take metformin may also switch to GLP-1 agonists